Weight | 1 lbs |
---|---|
Dimensions | 9 × 5 × 2 in |
host | mouse |
isotype | IgG1 |
clonality | monoclonal |
concentration | 1 mg/mL |
applications | ICC/IF, IHC, WB |
reactivity | human, mouse, rat |
available sizes | 1 mg, 100 µg, 25 µg |
mouse anti-GFAP monoclonal antibody (2A5) 3682
$100.00 – $2,600.00
Antibody summary
- Mouse monoclonal to GFAP
- Suitable for: WB, ICC/IF, IHC
- Reacts with: human, mouse, rat
- Isotype: IgG1
- 100 µg, 25 µg, 1 mg
mouse anti-GFAP monoclonal antibody (2A5) 3682
target relevance |
---|
Glial Fibrillary Acidic Protein (GFAP) is a crucial cell marker widely employed in neuroscience and neurobiology research. It is an intermediate filament protein primarily found in astrocytes, a type of glial cell in the central nervous system. GFAP serves as a reliable marker for identifying and characterizing astrocytes in various experimental models and tissues. Immunohistochemistry and immunofluorescence techniques using antibodies targeting GFAP enable researchers to visualize and quantify astrocytic populations, gaining insights into their distribution, morphology, and function in the brain. Moreover, GFAP antibodies are instrumental in studying astrocyte reactivity, a phenomenon occurring in response to brain injury or neurodegenerative diseases. As astrocytes play critical roles in neural development, neurotransmitter regulation, and maintenance of the blood-brain barrier, GFAP has proven indispensable in advancing our understanding of glial biology and its contribution to neurological disorders. Click for more on: cell markers and GFAP |
Protein names Glial fibrillary acidic protein (GFAP) |
Gene names GFAP,GFAP |
Protein family Intermediate filament family |
Mass 49880Da |
Function GFAP, a class-III intermediate filament, is a cell-specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells. |
Subellular location Cytoplasm Note=Associated with intermediate filaments. |
Tissues Expressed in cells lacking fibronectin. |
Structure Interacts with SYNM. ; [Isoform 2]: Interacts with PSEN1 (via N-terminus). |
Post-translational modification Phosphorylated by PKN1. |
Involvement in disease Alexander disease (ALXDRD) [MIM:203450]: A rare disorder of the central nervous system. The most common form affects infants and young children, and is characterized by progressive failure of central myelination, usually leading to death within the first decade. Infants with Alexander disease develop a leukodystrophy with macrocephaly, seizures, and psychomotor retardation. Patients with juvenile or adult forms typically experience ataxia, bulbar signs and spasticity, and a more slowly progressive course. Histologically, Alexander disease is characterized by Rosenthal fibers, homogeneous eosinophilic inclusions in astrocytes. Note=The disease is caused by variants affecting the gene represented in this entry. |
Target Relevance information above includes information from UniProt accession: P14136 |
The UniProt Consortium |
Publications
pmid | title | authors | citation |
---|---|---|---|
36419095 | Novel localization of folate transport systems in the murine central nervous system | Sangha V, Hoque MT, Henderson JT, Bendayan R. | Fluids Barriers CNS. 2022 Nov 23;19(1):92. doi: 10.1186/s12987-022-00391-3. |
36160643 | Ji-Chuan decoction ameliorates slow transit constipation via regulation of intestinal glial cell apoptosis | Wang XM, Lv LX, Qin YS, Zhang YZ, Yang N, Wu S, Xia XW, Yang H, Xu H, Liu Y, Ding WJ. | World J Gastroenterol. 2022 Sep 14;28(34):5007-5022. doi: 10.3748/wjg.v28.i34.5007. |
35850708 | Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma | Sainero-Alcolado L, Mushtaq M, Liaño-Pons J, Rodriguez-Garcia A, Yuan Y, Liu T, Ruiz-Pérez MV, Schlisio S, Bedoya-Reina O, Arsenian-Henriksson M. | J Exp Clin Cancer Res. 2022 Jul 19;41(1):226. doi: 10.1186/s13046-022-02399-x. |
35808977 | Characterisation of the consequences of maternal immune activation on distinct cell populations in the developing rat spinal cord | Anderson RC, O'Keeffe GW, McDermott KW. | J Anat. 2022 Oct;241(4):938-950. doi: 10.1111/joa.13726. Epub 2022 Jul 9. |
35778934 | The LncRNA AK018453 regulates TRAP1/Smad signaling in IL-17-activated astrocytes: A potential role in EAE pathogenesis | Zhang Q, Yang Y, Chen Y, Wang Y, Qin S, Lv R, Zhou M, Yu Q, Li X, Li X, Wang X, You H, Wang Y, Zhou F, Liu X. | Glia. 2022 Nov;70(11):2079-2092. doi: 10.1002/glia.24239. Epub 2022 Jul 2. |
relevant to this product |
---|
Western blot IHC ICC |
# | SDS | Certificate | Datasheet |
---|---|---|---|
Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information. |
15 reviews for mouse anti-GFAP monoclonal antibody (2A5) 3682
Only logged in customers who have purchased this product may leave a review.
verified user –
verified user –
verified user –
verified user –
verified user –
verified user –
verified user –
verified user –
verified user –
verified user –
verified user –
verified user –
verified user –
verified user –
verified user –